Piperacillin and Tazobactam
Piperacillin and Tazobactam is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Piperacillin and Tazobactam; Generic name: PIPERACILLIN AND TAZOBACTAM; Manufacturer: WG Critical Care, LLC.
| Brand name | Piperacillin and Tazobactam |
|---|---|
| Generic name | PIPERACILLIN AND TAZOBACTAM |
| Manufacturer | WG Critical Care, LLC |
| Used for | 1 INDICATIONS AND USAGE Piperacillin and tazobactam for injection, for intravenous use is a combination of piperacillin, a penicillin-class antibacterial and tazobactam, a β-lactamase inhibitor indicated for the treatment of: • Intra-abdominal infections in adult and pediatric patients 2 months of age and older ( 1.1 ) • Nosocomial pneumonia in adult and pediatric patients 2 months of age and older ( 1.2 ) • Skin and skin structure infections in adults ( 1.3 ) • Female pelvic infections in adults ( 1.4 ) • Community-acquired pneumonia in adults ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of Piperacillin and Tazobactam for Injection, USP and oth |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Adult Patients With Indications Other Than Nosocomial Pneumonia: The usual daily dosage of piperacillin and tazobactam for adults is 3.375 g every six hours totaling 13.5 g (12.0 g piperacillin and 1.5 g tazobactam) ( 2.1 ) • Adult Patients with Nosocomial Pneumonia: Initial presumptive treatment of patients with nosocomial pneumonia should start with piperacillin and tazobactam at a dosage of 4.5 g every six hours plus an aminoglycoside, totaling 18.0 g (16.0 g pip |
| Warnings | PHARMACY BULK PACKAGE-NOT FOR DIRECT INFUSION |
| Active ingredient(s) | PIPERACILLIN SODIUM |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17a400ae-cbaa-4d07-95f4-c6917dfc0585 |